ZTS Forensic analysis
Price Targets (12m)
Detailed research
PART 1: TRADING EXECUTION
Trading Setup & Entry Strategy
Zoetis (ZTS) is currently in a state of technical capitulation, with a 20-day price decline of 33.22% and an RSI of 23.60, signaling extreme oversold conditions. While the fundamental narrative is tarnished by the Q1 earnings miss and guidance cuts, the technicals suggest a mean-reversion opportunity is building.
- >Entry Zone: $77.00 - $79.50. Scale in 40% here. Add 30% on a retest of the absolute low at $74.00, and 30% if we see a confirmed break above the 10-day SMA ($81.57).
- >Stop Loss: $70.00 (Hard stop). A break below the psychological $70 level would invalidate the recovery thesis.
- >Take Profit: $95.00 (Initial target) and $105.00 (Secondary target, near the 50-day SMA).
- >Risk/Reward: ~1:2.5 initial setup.
PART 2: DETAILED RESEARCH
Recent Material Events & Financial Health
Q1 2026 results disappointed, with a clear narrative shift toward increased competition and consumer sensitivity impacting the US Companion Animal segment. The Fiscal Year Alignment accounting change created noise, but the underlying organic decline in key franchises like dermatology and Simparica Trio is the core concern.
Insider Trading Activity
Recent activity is encouraging. On 2026-05-13, Michael McCallister purchased $233K of stock. Insider buying near multi-year lows often serves as a floor for sentiment.
Technical Analysis & Trade Timing
- >RSI (14-day): 23.60 (Deeply Oversold). Typically a contrarian buy signal.
- >Trend: BEARISH_DOWNTREND. The stock is trading significantly below its 50-day SMA ($110.27) and 200-day SMA ($128.41).
- >Reconciliation: The fundamentals are currently in a "Value Trap" status due to the negative revision cycle. However, the extreme technical oversold condition indicates a high probability of a relief bounce. We are prioritizing a Swing Trade over a long-term position.
Short-Term Trading Strategy (2-5 Days)
- >Timeframe: Swing Trade (2–5 Days).
- >Position Size: 3% of Portfolio.
- >Max Hold: 2 weeks. If the stock does not reclaim the 10-day SMA by then, the momentum is dead.
- >Catalyst: Institutional re-rating following the recent analyst price target cuts (Citi/Morgan Stanley). The "washout" selling of the last 20 days is likely near exhaustion.
One-Liner Thesis: ZTS is currently experiencing a technical washout; we are playing a mean-reversion trade, supported by insider buying, while respecting the bearish trend until it crosses the 10-day SMA.